Source: Read Here!
Meanwhile, the price of the company's stock has soared as media coverage of the Ebola outbreak has intensified...!
Tekmira Pharmaceuticals says the trial was halted because it seemed clear that continuing was not likely to show that the drug works.
The drug is called TKM-Ebola. It was being tested with Ebola patients in Sierra Leone.
Dr. Peter Horby, the chief investigator of the trial, says the drug has not been shown to benefit patients. - Read More -
Burnaby, B.C.-based Tekmira Pharmaceuticals says the trial was halted because it seemed clear that continuing was not likely to show that the drug works.
- Read More -
Horby says data from the trial still need to be analyzed.
Horby is with the University of Oxford, which was conducting the trial. - Read More -
- Read More -
Dr. Boyle: "It seems to me that [the Ebola epidemic in West Africa] has U.S. biowarfare programs written all over it." (Read Here!)
In that very case: Are You Asthmatic?
It might hep somebody, but it might also harm. Trials like this one are usually paid, between £2000 - £6000 Pounds....!
The (USA) FDA's definition of a "serious adverse reaction" to a vaccine includes a reaction that leads to:
- Permanent disability
- Life-threatening event
- >>>>> Read also MERCOLAS article!!!
Read all about Ebola Ghana Test at our Special Extra page!